Recent Finacing
Recent Raise
ARTHEx Biotech is a Valencia-based clinical-stage biotech developing targeted RNA medicines for rare genetic neuromuscular disorders, led by its Phase I/IIa candidate ATX-01 for myotonic dystrophy type 1.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ARTHEx Biotech.
